Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Get this in your inbox everyday by subscribing to our newsletters.
5. Haemonetics sees shares rise on Q1 release
Haemonetics has seen shares rise despite releasing 1st quarter earnings that saw losses grow and earnings per share shrink compared to last year.
The Braintree, Mass.-based company reported losses of $10.3 million, or 20¢ per share, on sales of $210 million for the 3 months ended July 2. Read more
4. Intersect ENT files with FDA for drug-delivering sinus implant
Intersect ENT said today it submitted a supplemental premarket approval submission to the FDA seeking approval for a new Nova steroid releasing implant for treating patients with chronic sinus disease.
The new Nova device is designed with a lower profile to allow for placement in smaller sinus openings, and will expand the usable patient population for the steroid releasing implants, the Menlo Park, Calif.-based company said. Read more
3. Intuitive partners with Dextera on robotic surgery stapler
Intuitive Surgical said it inked a joint development deal with Dextera Surgical to develop a surgical stapler and cartridge for Intuitive’s da Vinci robotic surgical system.
The company said the new development follows completion of a 6-month feasibility evaluation of Dextera’s MicroCutter as part of an ongoing deal between the companies. Read more
2. Medtronic wins expanded CE Mark for Evolut R TAVR system
Medtronic said today it won expanded CE Mark approval in the European Union for its CoreValve Evolut R transcatheter aortic valve replacement, now approved for aortic stenosis patients at intermediate risk for open-heart surgery.
The Fridley, Minn.-based company touted the win, saying it is the 1st TAVI system to have received expanded indication in Europe for patients at intermediate risk for open heart surgery. Read more
1. Verily, GlaxoSmithKline partner to form $713m joint Galvani Bioelectronics
GlaxoSmithKline said today it is partnering with Google‘s Verily to form Galvani Bioelectronics, a new firm focused on bioelectronic medicine.
Bioelectronic medicine operates around using miniaturized, implantable devices, much like neuromodulation devices, designed to modify electrical signals through nerves for a variety of different effects, including pain relief and chronic condition management, the company said. Read more
The post MassDevice.com +5 | The top 5 medtech stories for August 1, 2016 appeared first on MassDevice.
from MassDevice http://ift.tt/2apv9Mr
Cap comentari:
Publica un comentari a l'entrada